Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $45.3700 (-4.44%) ($45.1100 - $48.3500) on Thu. Aug. 4, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.71% (three month average) | RSI | 38 | Latest Price | $45.3700(-4.44%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -2.1% a day on average for past five trading days. | Weekly Trend | HALO declines -2.3% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(40%) IWM(35%) IWO(35%) IWN(34%) IFRA(33%) | Factors Impacting HALO price | HALO will decline at least -1.355% in a week (0% probabilities). VIXM(-13%) UUP(-8%) VXX(-6%) TBT(-5%) GLD(3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.355% (StdDev 2.71%) | Hourly BBV | -2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $49.28 | 5 Day Moving Average | $47.61(-4.7%) | 10 Day Moving Average | $49.04(-7.48%) | 20 Day Moving Average | $49.28(-7.93%) | To recent high | -12.5% | To recent low | 21.4% | Market Cap | $6.201b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |